IP Library Granted Patent US 8,062,874
Granted Patent B2
US 8,062,874 · App. 10/482,980 · Granted Nov 22, 2011

GFP fusion proteins and their use

Assignee: The Board of Trustees of the University of Illinois
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,062,874
App. No.
10/482,980
Granted
Nov 22, 2011
Kind
B2
Abstract

The present invention provides fusion proteins including a green fluorescent protein inserted into the internal amino acid sequence of a Gαs protein and further provides method of using the fusion protein construct to follow activation of a G-protein receptor by a candidate drug.

Claims (14)

1. A fusion protein comprising a green fluorescent protein inserted between the GTPase and the helical domain of Gα S , wherein the Gα S activates adenylyl cyclase and the fusion protein translocates from the plasma membrane into the cytoplasm upon activation.

2. The fusion protein of claim 1 , wherein the insertion is at regions that are free of interactions with receptors or effectors.

3. The fusion protein of claim 1 modified for specific receptors by replacing amino acid residues at the C terminal end of Gα s .

4. A method for making a fusion protein, said method comprising:

(a) obtaining a molecule having the amino acid sequence of a green fluorescent protein; and

(b) inserting the molecule between the GTPase and the helical domain of Gα S .

5. The method of claim 4 wherein the fusion protein has the amino acid sequence of SEQ ID NO: 2.

6. A method to follow an activation of a G-protein receptor by a candidate drug said method comprising:

(a) obtaining a Gα s green fluorescent fusion protein, wherein the green fluorescent protein is inserted between the GTPase and the helical domain of Gα S ;

(b) monitoring fluorescence of the fusion protein in response to the candidate drug;

(c) inferring from a change in membrane fluorescence whether the drug is an agonist or antagonist; and

(d) following the activation of the G-protein receptor by the candidate drug.

7. The fusion protein of claim 1 comprising the amino acid sequence of SEQ ID NO: 2.

8. The fusion protein of claim 1 , wherein the fusion protein internalizes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 15, 2011
From: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS ON BEHALF OF ITS OFFICE OF TECHNOLOGY MANAGEMENT OFFICE AT THE UNIVERSITY OF ILLINOIS AT CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027389/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2004
From: RASENICK, MARK M.; YU, JIANG-ZHOU
To: BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE
Reel/Frame 015165/0592 →
Continuity (2)
Provisional Application 60303622 · Jul 6, 2001
Related Publication 20060247418A1 · Nov 2, 2006